Intellia Therapeutics, Inc. (0JBU.L)
USD 8.89
(-6.09%)
USD 8.89
(-6.09%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -481.19 Million USD | 1.84% |
| 2022 | -490.2 Million USD | -88.75% |
| 2021 | -259.71 Million USD | -106.83% |
| 2020 | -125.56 Million USD | -35.46% |
| 2019 | -92.69 Million USD | -8.62% |
| 2018 | -85.34 Million USD | -26.35% |
| 2017 | -67.54 Million USD | -113.51% |
| 2016 | -31.63 Million USD | -155.17% |
| 2015 | -12.39 Million USD | 13.36% |
| 2014 | -14.3 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -107.43 Million USD | 18.71% |
| 2024 Q2 | -146.97 Million USD | -36.8% |
| 2023 Q2 | -123.68 Million USD | -33.94% |
| 2023 FY | -481.19 Million USD | 1.84% |
| 2023 Q4 | -132.16 Million USD | -8.13% |
| 2023 Q1 | -92.34 Million USD | 20.89% |
| 2023 Q3 | -122.22 Million USD | 1.18% |
| 2022 Q1 | -146.87 Million USD | -80.79% |
| 2022 Q4 | -116.72 Million USD | -3.09% |
| 2022 Q3 | -113.22 Million USD | -13.26% |
| 2022 Q2 | -99.97 Million USD | 31.93% |
| 2022 FY | -490.2 Million USD | -88.75% |
| 2021 Q3 | -71.64 Million USD | -4.12% |
| 2021 Q4 | -81.23 Million USD | -13.39% |
| 2021 FY | -259.71 Million USD | -106.83% |
| 2021 Q1 | -46.2 Million USD | -9.51% |
| 2021 Q2 | -68.8 Million USD | -48.91% |
| 2020 Q4 | -42.19 Million USD | -51.55% |
| 2020 FY | -125.56 Million USD | -35.46% |
| 2020 Q1 | -31.8 Million USD | -12.48% |
| 2020 Q3 | -27.84 Million USD | 14.06% |
| 2020 Q2 | -32.39 Million USD | -1.85% |
| 2019 Q3 | -23.63 Million USD | 7.98% |
| 2019 FY | -92.69 Million USD | -8.62% |
| 2019 Q1 | -21.94 Million USD | -15.07% |
| 2019 Q4 | -28.27 Million USD | -19.64% |
| 2019 Q2 | -25.68 Million USD | -17.06% |
| 2018 Q4 | -19.06 Million USD | 16.02% |
| 2018 FY | -85.34 Million USD | -26.35% |
| 2018 Q3 | -22.7 Million USD | -2.17% |
| 2018 Q2 | -22.21 Million USD | -4.04% |
| 2018 Q1 | -21.35 Million USD | 10.88% |
| 2017 FY | -67.54 Million USD | -113.51% |
| 2017 Q3 | -15.35 Million USD | 1.52% |
| 2017 Q2 | -15.59 Million USD | -23.45% |
| 2017 Q4 | -23.96 Million USD | -56.05% |
| 2017 Q1 | -12.63 Million USD | -19.58% |
| 2016 FY | -31.63 Million USD | -155.17% |
| 2016 Q4 | -10.56 Million USD | -41.18% |
| 2016 Q3 | -7.48 Million USD | -8.43% |
| 2016 Q2 | -6.9 Million USD | -3.15% |
| 2016 Q1 | -6.68 Million USD | -27.53% |
| 2015 FY | -12.39 Million USD | 13.36% |
| 2015 Q3 | -3.01 Million USD | 0.69% |
| 2015 Q4 | -5.24 Million USD | -73.73% |
| 2015 Q1 | -1.09 Million USD | 84.85% |
| 2015 Q2 | -3.04 Million USD | -178.13% |
| 2014 FY | -14.3 Million USD | 0.0% |
| 2014 Q4 | -7.21 Million USD | 0.0% |
| 2014 Q2 | -178 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 387.03% |
| Aclaris Therapeutics, Inc. | -88.48 Million USD | -443.837% |
| Myriad Genetics, Inc. | -112 Million USD | -329.636% |
| Evolus, Inc. | -61.68 Million USD | -680.079% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -31.371% |
| Agilent Technologies, Inc. | 1.24 Billion USD | 138.806% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -36.668% |
| uniQure N.V. | -308.47 Million USD | -55.989% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -912.929% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -74.265% |
| bluebird bio, Inc. | -211.91 Million USD | -127.071% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -788.005% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -9.302% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 553.356% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -217.442% |
| Dynavax Technologies Corporation | -6.38 Million USD | -7431.57% |
| Editas Medicine, Inc. | -153.21 Million USD | -214.055% |
| FibroGen, Inc. | -284.23 Million USD | -69.296% |
| Geron Corporation | -184.12 Million USD | -161.337% |
| Blueprint Medicines Corporation | -506.98 Million USD | 5.087% |
| IQVIA Holdings Inc. | 1.35 Billion USD | 135.434% |
| Illumina, Inc. | -1.16 Billion USD | 58.554% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -8.368% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | -1040.292% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 292.708% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -306.025% |
| Adicet Bio, Inc. | -142.65 Million USD | -237.305% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 10.222% |
| Insmed Incorporated | -749.56 Million USD | 35.804% |
| Mettler-Toledo International Inc. | 788.77 Million USD | 161.005% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1107.205% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 36664.742% |
| Walgreens Boots Alliance, Inc. | -8.63 Billion USD | 94.428% |
| Waters Corporation | 642.23 Million USD | 174.925% |
| Zoetis Inc. | 2.34 Billion USD | 120.529% |
| Thermo Fisher Scientific Inc. | 5.99 Billion USD | 108.027% |
| Biogen Inc. | 1.16 Billion USD | 141.443% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -86.631% |
| Nektar Therapeutics | -276.05 Million USD | -74.31% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -460.21% |
| Perrigo Company plc | -12.7 Million USD | -3688.913% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -101.135% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -335.235% |
| Verastem, Inc. | -87.36 Million USD | -450.771% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 113.294% |
| Imunon, Inc. | -19.51 Million USD | -2365.757% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -978.826% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | -129.963% |
| Homology Medicines, Inc. | -53.74 Million USD | -795.358% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 112.171% |
| OPKO Health, Inc. | -188.86 Million USD | -154.784% |
| Exelixis, Inc. | 207.76 Million USD | 331.604% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 270.881% |
| TG Therapeutics, Inc. | 12.67 Million USD | 3897.285% |
| Incyte Corporation | 597.59 Million USD | 180.521% |
| Emergent BioSolutions Inc. | -760.5 Million USD | 36.727% |